MapLight Therapeutics, Inc.

US$6.93As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MPLTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (111.55%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (59.04%)
Mkt cap US$385.1M
ROIC (72.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.70
25.61%
(75.03%)
Hold 12|11|4|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.17
0.18
0.18
27.35%
24.71%
21.87%
22.58%
Revenue$M
19.24
19.45
19.29
19.51
13.25%
10.27%
5.32%
1.77%
Peers (US$385.1M)
Cap (US$)
PE
394.0M
—
386.6M
36.53x
Capital
TTM
5Y
10Y
Leveragex
0.112
0.789
0.606
EBIT/Intx
1.684
0.207
0.234
Own earn%
(104.89)
75.42
62.97
Sh yield%
38.81
47.59
45.15
Owners
Insiders/Inst%
10.18
69.03
Short interest%
0.61
SBC / revenue%
2.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
13–17
$1 testx
−0.1
Incr. ROIC%
2